Esperanza Rivera de Torre

Postdoctoral Researcher at DTU in the @CAT4science. Discovering antibody-based antivenoms and make my way on the allergy field. Opinions on my own.

[Andreas Laustsen @AndreasLaustsen]

Excited to share our new study showing how combining consensus #allergens with intracellular delivery via #mRNA-LNP technology could help treat #allergy: https://t.co/hC2mu1lNKx
Led by @esperdet and a fantastic international team across academia and industry!

[AffinityAI @affinityaibio]

Whether you're on holiday 🏖️ or still in the lab 🧪 trying to keep cool, at least one thing isn't melting: our DesignerBodies.

Generatively designed. Thermally stable ❄️ Reliable reagents that don’t need a break 💪

#ProteinDesign #AI #Biotech

[James Rooney @RedBeardRooney]

Have you ever woken up in a cold sweat in the middle of the night and wondered how gastrointestinal nematodes influence the composition of their host’s gut microbiota? 🪱🦠

Worry no more!! I am excited to share our latest findings! 🧵⤵️

https://t.co/MyNBLY7c3k

[Esperanza Rivera de Torre @esperdet]

This research is the result of an international collaboration network including @DTUbioengineer, @unicomplutense, @vallhebron, @hospitalclinic, @DTU_HealthTech and it could not have been possible without the support from @DTUSkylab, @ERC_Research, and @Innofond

[Esperanza Rivera de Torre @esperdet]

This research is especially important for me as it means a fundamental shift in my career to immunology. I am very much looking forward to applying everything I know about #proteindesign and #biophysics in this exciting field. I am looking forward to the reviewer's comments

[Esperanza Rivera de Torre @esperdet]

I am very excited to share my latest #preprint about the use of consensus allergens and #mRNA as a new class of #allergyimmunotherapy for multiple allergens. The results are preliminary but promising!
https://t.co/sa1umpmb6z

[Esperanza Rivera de Torre @esperdet]

📃 If you are curious and want to know more about our research, access the full paper here and save the reference for later: https://t.co/aq17ZciQAF
We are already working on other applications of the #consensus technology!
#antivenom #antibododytechnology #academia

[Esperanza Rivera de Torre @esperdet]

🎉 Exciting News! 📚 I'm thrilled to share that my second paper of 2024 is published in Protein Science, focusing on consensus toxins and their role in developing #broadlyneutralizing antibodies. Keep reading to discover its technological potential 🧵https://t.co/aq17ZciQAF

[Esperanza Rivera de Torre @esperdet]

A big thank you to my co-authors Mark, Stefanos, Markus, @AndreasLaustsen, and Seyed for their invaluable contributions. Special thanks to our funders: @wellcometrust , @ERC_Research , and @VILLUMFONDEN , for their support in this important work.

[Andreas Laustsen @AndreasLaustsen]

Excited to share our new research findings on the expression of the challenging toxin, alpha-cobratoxin, in both E. coli and yeast-based expression systems!
Thanks to fantastic co-authors and funders :-)

[Esperanza Rivera de Torre @esperdet]

Huge thanks to the researchers that made this possible! @AndreasLaustsen @SelmaBelfakir @DamsboAnna Nick, Charlotte et. al from @CAT4Science @DTUtweet @DTUbioengineer and @VenomAid_dx for the great teamwork and our funders @VILLUMFONDEN @wellcometrust @Innofond @ERC_Research

[Esperanza Rivera de Torre @esperdet]

Excited to announce that our research on producing snake toxins in bacteria and yeast systems has been published in Toxicon! do you want to know more about this research developed at @DTUbioengineer @CAT4Science? Keep reading 👇

https://t.co/aFXHrlmbgh

[Esperanza Rivera de Torre @esperdet]

If you want to dive into the details, visit our paper and save the reference for the future here: https://t.co/aFXHrlmbgh